Massachusetts Cannabis Regulators Issue Consumer Warning After Testing Lab Suspension
Advisory Comes One Month After License Suspension of Assured Testing Laboratories
Just over a month after halting the operations of a cannabis testing lab accused of approving contaminated marijuana for sale, the Massachusetts Cannabis Control Commission (CCC) has issued a public health and safety advisory.
On August 6, 2025, the CCC urged marijuana consumers to carefully review the labels on their cannabis products to determine whether they were tested by Assured Testing Laboratories between April 2024 and April 2025.
The advisory is notable for what it is not: it is not a formal recall. Instead, the CCC’s notice offers consumers the option to “destroy or return” any affected products, many of which may have already been consumed long ago.
Allegations of Faulty Testing and Contaminated Cannabis Approval
The CCC’s June 30 suspension order alleged that Assured Testing Laboratories, based in Tyngsboro, Massachusetts, failed to accurately report test results for contaminants during the year-long period in question.
Among the most troubling allegations was that Assured’s failure rate for yeast and mold detection was 90 times lower than the statewide average—a statistic that regulators suggest may indicate manipulated or inaccurate testing results.
The lab was responsible for testing approximately one-quarter of all cannabis in Massachusetts during that year. The potential scope of the issue is therefore significant, raising questions about whether contaminated cannabis entered the market undetected.
Over 7,500 Products Flagged But No Brands or Retailers Identified
In its advisory, the CCC disclosed that more than 7,500 cannabis products had been tested by Assured within the affected timeframe. These products were identified by name and their Metrc ID tags, the tracking numbers used in the state’s cannabis seed-to-sale system.
However, the advisory notably did not name any brands, cultivators, or retailers associated with these products. This omission means that while consumers are encouraged to check their product labels, they are largely on their own in identifying whether their purchases might be among those flagged.
Some of these products were sold more than a year ago, meaning much of the potentially contaminated cannabis has already been consumed.
Regulators Shift Responsibility to Consumers and Retailers
In its advisory, the CCC placed much of the responsibility for addressing the issue on both consumers and licensees.
“Consumers and patients that possess any of the affected products may destroy them or return them to the licensee where they were purchased for disposal and/or contact them for more information,” the CCC’s statement read.
The advisory also instructed cannabis businesses to follow their internal recall procedures for any affected products, though it stopped short of mandating a coordinated, statewide recall effort.
As of Thursday, it was not immediately clear whether any significant amount of product had actually been returned by consumers.
Pattern of Delayed Recalls in Cannabis Regulation
The situation in Massachusetts reflects a broader issue in cannabis regulation nationwide.
Other states have faced criticism for slow-moving investigations and delayed recall notices that often come too late to prevent the consumption of potentially contaminated cannabis.
In some cases, the lack of speed in addressing contamination issues is due to lengthy administrative processes, legal disputes, or the sheer scale of investigations. As a result, even when product problems are identified, much of the affected inventory has already been used by the time consumers are warned.
Industry-Wide Concerns Over Lab Practices
The suspension of Assured Testing Laboratories follows growing concerns across the U.S. about the reliability and integrity of cannabis testing labs.
In multiple states, regulators and whistleblowers have accused certain labs of inflating THC potency results, a marketing advantage for brands—and failing to detect contaminants such as pesticides, mold, and heavy metals.
The incentive to produce favorable results can be strong, given the competitive nature of cannabis retail and the pressure to meet consumer demand for high-THC products. Critics argue that this creates an environment ripe for “lab shopping,” where cultivators and manufacturers choose testing facilities based on their perceived leniency rather than their rigor.
First Crackdown on a Massachusetts Cannabis Testing Lab
While testing controversies have surfaced in other states, the CCC’s suspension of Assured marks the first time Massachusetts regulators have taken such decisive action against a licensed cannabis testing facility.
This action suggests that state officials are becoming more aggressive in enforcing quality standards and protecting public health in the cannabis sector. However, some advocates question whether the CCC’s measured advisory—without a full recall—goes far enough to safeguard consumers.
Assured Testing Laboratories Denies Wrongdoing and Files Lawsuit
Assured Testing Laboratories has pushed back strongly against the CCC’s allegations.
The company has since filed a lawsuit against the CCC in an effort to restore its suspended license, arguing that the commission’s findings are flawed and that its operations have been unfairly halted.
What Consumers Should Do Now
For Massachusetts cannabis customers, the immediate recommendation from the CCC is to:
- Check the label of any cannabis products purchased between April 2024 and April 2025.
- Look for the name “Assured Testing Laboratories” or relevant identifiers in the test lab field.
- If the product is listed in the advisory, either destroy it or return it to the store where it was purchased.
The CCC’s website contains the full list of affected products and their Metrc ID numbers, though no additional identifying details such as brand names or retailers are provided.
The Road Ahead for Cannabis Testing Oversight in Massachusetts
The Assured case could set a precedent for how Massachusetts—and possibly other states—approach enforcement against cannabis testing labs suspected of misconduct.
Regulators face a delicate balance: ensuring public safety while avoiding disruption to a supply chain that serves both recreational consumers and medical patients. The outcome of Assured’s legal challenge will be closely watched by industry stakeholders, consumers, and other state regulators.
In the meantime, the CCC’s decision not to order a full recall leaves the burden of action primarily on consumers and cannabis businesses themselves.
For critics, this raises a key question: in a market built on public trust, should responsibility for product safety fall so heavily on the end user?
Topic(s):
OG source Download Article 
